Single-dose genome editing therapy rescues auditory and vestibular functions in adult mice with DFNA41 deafness
Journal of Clinical Investigation · 15.10.2025 · 135 (20)
DOI: 10.1172/jci187872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 14.08.2025. Verfasst von Wei Wei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Graduate Program in Speech and Hearing Bioscience and Technology and Program in Neuroscience, Har…. Hauptthemen laut MEDLINE: Gene Editing, Genetic Therapy, Deafness, Vestibule, Labyrinth. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, NCATS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Genome editing has the potential to treat genetic hearing loss. However, current editing therapies for genetic hearing loss have shown efficacy only in hearing rescue. In this study, we evaluated a rescue strategy using adeno-associated virus (AAV) type 2–mediated delivery of Staphylococcus aureus Cas9-sgRNA in the mature inner ear of the P2rx2 V61L/+ mouse model of autosomal dominant deafness-41 (DFNA41), a dominant, delayed-onset, and progressive hearing loss in humans. We demonstrate that local injection in adult mice results in efficient and specific editing that abolishes the mutation without notable off-target effects or AAV genome integration. Editing effectively restores long-term auditory and vestibular function. Editing further protects P2rx2 V61L/+ mice from hypersensitivity to noise-induced hearing loss, a phenotype also observed in patients with DFNA41. Intervention in mice at a juvenile stage broadens the frequency range rescued, highlighting the importance of early intervention. An effective and specific gRNA for the human P2RX2 V60L mutation has been identified. Our study establishes the feasibility of editing to treat DFNA41 caused by P2RX2 V60L mutation in humans and opens an avenue for using editing to rescue hearing and vestibular function while mitigating noise-induced hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Graduate Program in Speech and Hearing Bioscience and Technology and Program in Neuroscience, Harvard Medical School, Boston, Massachusetts, USA.
- Eaton-Peabody Laboratory, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
- Dr. John T. Macdonald Foundation Department of Human Genetics and.
- John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA.
- ENT Institute and Otorhinolaryngology Department of Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science.
- Institutes of Biomedical Science, and.
Förderung
- NIDCD NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- U.S. Department of Defense
Zitieren
APA
Wei, W., Zhu, W., Silver, S., Armstrong, A. M., Robbins, F. S., Rameshbabu, A. P., Walz, K., Quan, Y., Du, W., Kim, Y., Indzhykulian, A. A., Shu, Y., Liu, X. Z., & Chen, Z. Y. (2025). Single-dose genome editing therapy rescues auditory and vestibular functions in adult mice with DFNA41 deafness. Journal of Clinical Investigation, 135(20). https://doi.org/10.1172/jci187872
Vancouver
Wei W, Zhu W, Silver S, Armstrong AM, Robbins FS, Rameshbabu AP, et al. Single-dose genome editing therapy rescues auditory and vestibular functions in adult mice with DFNA41 deafness. Journal of Clinical Investigation. 2025;135(20). doi:10.1172/jci187872
BibTeX
@article{Wei2025,
author = {Wei, Wei and Zhu, Wenliang and Silver, Stewart and Armstrong, Ariel M and Robbins, Fletcher S and Rameshbabu, Arun Prabhu and Walz, Katherina and Quan, Yizhou and Du, Wan and Kim, Yehree and Indzhykulian, Artur A and Shu, Yilai and Liu, Xue-Zhong and Chen, Zheng-Yi},
title = {Single-dose genome editing therapy rescues auditory and vestibular functions in adult mice with DFNA41 deafness},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {20},
doi = {10.1172/jci187872}
}
EUVIMED